Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transmembrane protein 126A pseudogene is a genomic locus similar in sequence to the TMEM126A gene, which encodes a mitochondrial membrane protein involved in protein quality control and complex I assembly. However, as a pseudogene, ENSG00000248577 is typically non-functional and does not produce a protein product or participate directly in cellular signaling or therapeutic mechanisms. While some pseudogenes may influence gene regulation by acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges, there is no specific evidence supporting functional or therapeutic relevance for the TMEM126A pseudogene[5]. Pseudogenes are generally excluded as therapeutic or diagnostic targets unless proven otherwise. Key clarifications: - ENSG00000248577 does NOT represent the functional TMEM126A gene or protein (which has disease links such as optic atrophy[1][3]), but rather a non-protein-coding pseudogene. - Therapeutic targeting, clinical biomarkers, interacting drugs, and pharmacological mechanisms generally do not apply to pseudogenes in current medical practice[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 126A pseudogene.